Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) announced it has successfully closed the first tranche of its non-brokered private placement, bringing in $320,000 of gross proceeds.
It has issued 16 million units at $0.02 per unit, each comprising one common share and one warrant (exercisable at $0.05 for a period of 24 months).
Proceeds are earmarked for the company’s AI-driven health screening solutions, targeting enterprise and government clients in the United States.
Also, Predictmedix AI granted 2 million stock options to a consultant (exercisable at $0.05 per share and are valid for one year).